Qingdao Baheal Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QINGDAO BAHEAL PHARM, and what generic and branded alternatives to QINGDAO BAHEAL PHARM drugs are available?
QINGDAO BAHEAL PHARM has five approved drugs.
Drugs and US Patents for Qingdao Baheal Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Qingdao Baheal Pharm | CELECOXIB | celecoxib | CAPSULE;ORAL | 208856-001 | Aug 7, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Qingdao Baheal Pharm | METHIMAZOLE | methimazole | TABLET;ORAL | 040547-004 | Feb 18, 2005 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Qingdao Baheal Pharm | CELECOXIB | celecoxib | CAPSULE;ORAL | 208856-002 | Aug 7, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.